logo

Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash

By: odaily.com|2025/07/14 11:31:37

Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)

ZachXBT: Collaborates with Multiple Parties to Freeze Brazil Central Bank Service Provider Funds Involved in $5 Million Crypto Theft
Citi: The total circulating supply of stablecoins may increase to $1.6-3.7 trillion by 2030

You may also like

Share
copy

Gainers

Latest Crypto News

07:45

Japan's Interest Rate Hike Signal Triggers "Bloodletting" Worries in U.S. Markets, Fed's Rate Cut Prospect May Change

07:45

Lily Liu Criticizes The New York Times for Biased Reporting on Innovation and AI

07:15

BlackRock: Tokenization is evolving at a pace comparable to the early Internet, poised for significant growth

07:15

Whale "pension-usdt.eth" yesterday saw its ETH long position fall below the average price, with a position size reaching $56 million.

07:15

Dark Pool DEX HumidiFi to Launch ICO, Leading in Trading Volume Among Solana Ecosystem DEXs

Read more
Community
icon
icon
icon
icon
icon
icon
icon
icon

Customer Support@weikecs

Business Cooperation@weikecs

Quant Trading & MM[email protected]

VIP Services[email protected]